Evonik’s stock teeters near 52-week low as dividend fears grow
Evonik Stock: Critical Level at Risk
Evonik stock nears 52-week low after analysts cut valuation and express concerns about dividend coverage. Technical chart remains extremely tense.
2025-12-06T01:30:18+00:00
finance, investing, stock-market
Evonik’s share price has slumped to near its 52-week low after a series of analyst downgrades. Concerns over dividend coverage and weak market sentiment have pushed the stock into oversold territory. The company’s recent leadership announcement has done little to reverse the downward trend.
The stock is currently trading just above its lowest point in the past year. With a Relative Strength Index (RSI) of 15.8, analysts describe the shares as severely oversold. A key support level at €12.83 is now under close watch—any drop below this mark could trigger further selling.
Evonik’s shares remain under pressure as analysts warn of potential dividend shortfalls. The €12.83 support level is now critical, with further declines likely if it breaks. Leadership transitions have so far had no visible effect on the stock’s performance.
